[HTML][HTML] Discovery of potent chromone-based autotaxin inhibitors inspired by cannabinoids

MC Eymery, KA Nguyen, S Basu, J Hausmann… - European Journal of …, 2024 - Elsevier
Autotaxin (ATX) is an enzyme primarily known for the production of lysophosphatidic acid.
Being involved in the development of major human diseases, such as cancer and …

Structure-based discovery of novel chemical classes of autotaxin inhibitors

C Magkrioti, E Kaffe, EA Stylianaki, C Sidahmet… - International Journal of …, 2020 - mdpi.com
Autotaxin (ATX) is a secreted glycoprotein, widely present in biological fluids, largely
responsible for extracellular lysophosphatidic acid (LPA) production. LPA is a bioactive …

Design, synthesis, and biological evaluation of 2, 4-dihydropyrano [2, 3-c] pyrazole derivatives as autotaxin inhibitors

T Pantsar, P Singha, TJ Nevalainen, I Koshevoy… - European Journal of …, 2017 - Elsevier
Inhibition of Autotaxin (ATX) is a potential treatment strategy for several diseases, including
tumors with elevated ATX-lysophosphatidic acid (LPA) signaling. Combining structure …

Identification of two novel chemical classes of Autotaxin (ATX) inhibitors using Enalos Asclepios KNIME nodes

EA Stylianaki, VD Mouchlis, C Magkrioti… - Bioorganic & Medicinal …, 2024 - Elsevier
Autotaxin is a secreted lysophospholipase D which is a member of the ectonucleotide
pyrophosphatase/phosphodiesterase family converting extracellular …

“Hit” to lead optimization and chemoinformatic studies for a new series of Autotaxin inhibitors

EA Stylianaki, C Magkrioti, EM Ladopoulou… - European Journal of …, 2023 - Elsevier
Robust experimental evidence has highlighted the role of Autotaxin (ATX)/Lysophosphatidic
acid (LPA) axis not only in the pathogenesis of chronic inflammatory conditions and …

Development and therapeutic potential of autotaxin small molecule inhibitors: From bench to advanced clinical trials

AN Matralis, A Afantitis, V Aidinis - Medicinal research reviews, 2019 - Wiley Online Library
Several years after its isolation from melanoma cells, an increasing body of experimental
evidence has established the involvement of Autotaxin (ATX) in the pathogenesis of several …

Design, synthesis, docking and biological evaluation of 4-phenyl-thiazole derivatives as autotaxin (ATX) inhibitors

A Balupuri, DY Lee, MH Lee, S Chae, E Jung… - Bioorganic & Medicinal …, 2017 - Elsevier
The autotaxin-lysophophatidic acid (ATX-LPA) signaling pathway is involved in several
human diseases such as cancer, autoimmune diseases, inflammatory diseases …

Screening and X-ray crystal structure-based optimization of autotaxin (ENPP2) inhibitors, using a newly developed fluorescence probe

M Kawaguchi, T Okabe, S Okudaira… - ACS chemical …, 2013 - ACS Publications
Autotaxin (ATX), also known as ectonucleotide pyrophosphatase/phosphodiesterase 2
(ENPP2), was originally identified as a tumor cell autocrine motility factor and was found to …

Discovery and optimization of ATX inhibitors via modeling, synthesis and biological evaluation

A Balupuri, MH Lee, S Chae, E Jung, W Yoon… - European Journal of …, 2018 - Elsevier
Autotaxin (ATX) is a potential target for the treatment of various cancers. A new series of ATX
inhibitors was rationally designed and synthesized based on our previous study. Biological …

Discovery of Potent Selective Nonzinc Binding Autotaxin Inhibitor BIO-32546

B Ma, L Zhang, L Sun, Z Xin, G Kumaravel… - ACS Medicinal …, 2021 - ACS Publications
Autotaxin (ATX) is a lysophospholipase D that is the main enzyme responsible for
generating LPA in body fluids. Although ATX was isolated from a conditioned medium of …